TD Capital Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-237
| Closed | -$4.85K | – | 741 |
|
|
2025
Q1 | $4.85K | Hold |
237
| – | – | ﹤0.01% | 387 |
|
|
2024
Q4 | $5.36K | Buy |
237
+1
| +0.4% | +$23 | ﹤0.01% | 345 |
|
|
2024
Q3 | $5.8K | Hold |
236
| – | – | ﹤0.01% | 326 |
|
|
2024
Q2 | $5.45K | Buy |
236
+2
| +0.9% | +$46 | ﹤0.01% | 309 |
|
|
2024
Q1 | $5.64K | Hold |
234
| – | – | ﹤0.01% | 317 |
|
|
2023
Q4 | $5.39K | Buy |
234
+1
| +0.4% | +$23 | ﹤0.01% | 320 |
|
|
2023
Q3 | $4.75K | Sell |
233
-87
| -27% | -$1.77K | ﹤0.01% | 330 |
|
|
2023
Q2 | $7.48K | Hold |
320
| – | – | ﹤0.01% | 298 |
|
|
2023
Q1 | $7.44K | Sell |
320
-2,198
| -87% | -$51.1K | ﹤0.01% | 290 |
|
|
2022
Q4 | $63.4K | Sell |
2,518
-4,401
| -64% | -$111K | 0.01% | 150 |
|
|
2022
Q3 | $183K | Buy |
+6,919
| New | +$183K | 0.03% | 86 |
|
|
2022
Q1 | – | Sell |
-900
| Closed | -$39K | – | 215 |
|
|
2021
Q4 | $39K | Buy |
900
+5
| +0.6% | +$217 | ﹤0.01% | 176 |
|
|
2021
Q3 | $45K | Hold |
895
| – | – | 0.01% | 164 |
|
|
2021
Q2 | $47K | Buy |
895
+41
| +5% | +$2.15K | 0.01% | 154 |
|
|
2021
Q1 | $39K | Hold |
854
| – | – | 0.01% | 156 |
|
|
2020
Q4 | $39K | Buy |
+854
| New | +$39K | 0.01% | 144 |
|